M
MapLight Therapeutics, Inc. (MPLT)
NMS – Real Time Price. Currency in USD
33.28
+1.32 (4.13%)
At close: Jun 26, 2026, 4:00 PM EDT
32.61
-0.67 (-2.01%)
After-hours: Jun 26, 2026, 5:02 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
33.28
+1.32 (4.13%)
At close: Jun 26, 2026, 4:00 PM EDT
32.61
-0.67 (-2.01%)
After-hours: Jun 26, 2026, 5:02 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $55.7M significantly exceed its total debt $5.6M, ensuring strong financial flexibility
Total current assets $327.2M exceed Total current liabilities $14.3M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$51.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 22.91 | 6.05 | 10 | |
| Quick ratio | 22.91 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 9.0 | |
| Debt to Assets | 0.01 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -574K | -556K | -701K | -578K | -574K |
| Operating Income | -31M | -57M | -83M | -169M | -210M |
| Net Income | -30M | -56M | -78M | -161M | -199M |
| EBITDA | -31M | -57M | -82M | -169M | -209M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -15.63 | 1.0 |
| Next quarter | N/A | 96.67 | 5.5 |
| Current year | N/A | 72.21 | 5.5 |
| Next year | N/A | 12.77 | 4.5 |
| Weighted average score | 4.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 23.73 | 45.75 | -8.46 | 7.8 |
| Y/Y | 999 | -171.56 | N/A | -100.39 | 3.3 |
| 3y average | 999 | -77.51 | N/A | -72.61 | 3.3 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 3.9 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |